CDK1 and prostate adenocarcinoma: We demonstrated that all up-regulated (NCAPG, MKI67, TPX2, CCNA2, CCNB1) and all down-regulated (CDK1, CCNB2, AURKA, UBE2C, BUB1B, CENPF, RRM2) genes significantly affected (p < 0.001) the Gleason scores and TCGA-PRAD patients’ survival, as shown in Figure 10A–L.